155 related articles for article (PubMed ID: 32552953)
1. [Value of Serum Light Chain in Diagnosis and Evaluation of Efficacy for Multiple Myeloma].
Yu Y; Teng XJ; Luo GL; Wu LX; Guo BQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):886-893. PubMed ID: 32552953
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
Zhao D; Jiang JQ; Lin L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
[TBL] [Abstract][Full Text] [Related]
4. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
[TBL] [Abstract][Full Text] [Related]
5. [Value of Serum Free Light Chain Kappa/Lambda Ratio Detection Combined with Immunofixation Electrophoresis in the Prognosis Evaluation of Patients with Multiple Myeloma].
Jiang XN; Chen JF; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):191-195. PubMed ID: 32027275
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma].
Zhu AY; Zhu FB; Wang FC; Zhang LJ; Ma Y; Hu JG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1454-1459. PubMed ID: 29070124
[TBL] [Abstract][Full Text] [Related]
7. Poor performance of the total kappa/lambda light chain quantification in the diagnosis and follow-up of patients with multiple myeloma.
Zamora-Ortiz G; Velázquez-Sánchez-de-Cima S; Hernández-Reyes J; Martagón-Herrera NA; Ruiz-Argüelles A; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2014; 66(4):314-8. PubMed ID: 25695296
[TBL] [Abstract][Full Text] [Related]
8. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
9. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
Nelson M; Brown RD; Gibson J; Joshua DE
Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
Yang JJ; Zhang GS; Chen XR
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the screening value of serum light chain ratio, β2 microglobulin, lactic dehydrogenase and immunoglobulin in patients with multiple myeloma using ROC curves.
Ying L; Zhang X; Lu N; Zhao L; Nie Y; Wang G; Chen S; Xu L
PLoS One; 2023; 18(2):e0281743. PubMed ID: 36795719
[TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
13. POEMS Syndrome with IgG-λ/IgA-κ Biclonal Gammopathy and Abnormal Serum Free Light Chain Ratio: a Case Report.
Ham JY; Suh JS; Lee WK; Song KE
Ann Clin Lab Sci; 2015; 45(6):702-6. PubMed ID: 26663802
[TBL] [Abstract][Full Text] [Related]
14. Values of Immunoglobulin and Complements for Evaluating Treatment Outcomes of Patients with Multiple Myeloma.
Liu X; Zhou Z; Sun D
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948481
[TBL] [Abstract][Full Text] [Related]
15. Analytical performance and diagnostic potential of immunoassays determining intact immunoglobulin kappa/lambda ratios in monoclonal gammopathies.
Eckold J; Poenisch W; Drogies T; Kratzsch J; Teupser D; Thiery J; Bruegel M
Clin Lab; 2014; 60(9):1491-500. PubMed ID: 25291945
[TBL] [Abstract][Full Text] [Related]
16. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
[TBL] [Abstract][Full Text] [Related]
17. Correlations among different markers determined by immunochemical methods used for the diagnosis and monitoring of intact immunoglobulin multiple myeloma cases.
Dogaru M; Lazăr V; Coriu D
Roum Arch Microbiol Immunol; 2012; 71(4):183-200. PubMed ID: 23755700
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
Singh G
Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
[TBL] [Abstract][Full Text] [Related]
20. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.
Boyle EM; Fouquet G; Guidez S; Bonnet S; Demarquette H; Dulery R; Herbaux C; Noel MP; Manier S; Schraen S; Onraed B; Faucompré JL; Hennache B; Petillon MO; Mathiot C; Avet-Loiseau H; Facon T; Harding SJ; Moreau P; Leleu X
Cancer; 2014 Dec; 120(24):3952-7. PubMed ID: 25116271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
